PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Science Valley Research Institute, Santo André, São Paulo, Brazil; Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil. Electronic address: eduardoramacciotti@gmail.com.\', \'Science Valley Research Institute, Santo André, São Paulo, Brazil.\', \'Interdisciplinary Medicine in Cardiology Unit Heart Institute (InCor)- University of São Paulo Medical School, São Paulo, Brazil.\', \'Science Valley Research Institute, Santo André, São Paulo, Brazil; Hospital e Maternidade Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil.\', \'Universidade Estadual Paulista (UNESP), Botucatu, Brazil.\', \'Hospital das Clínicas de Ribeirão Preto, São Paulo University Medical School (USP), Ribeirão Preto, São Paulo, Brazil.\', \'Hospital do Rocio, Campo Largo, Paraná, Brazil.\', \'Irmandade da Santa Casa da Misericórdia de Santos, São Paulo, Brazil.\', \'Hospital Ana Neri, Salvador, Bahia, Brazil.\', \'Hospital Municipal de Barueri, São Paulo, Brazil.\', \'São Paulo State Public Women\'s Health Reference Center, São Paulo, Brazil.\', \'Hospital Israelita Albert Einstein, São Paulo, S.P., Brazil.\', \'Heart Institute (InCor)- University of São Paulo Medical School, São Paulo, Brazil.\', \'Institute of Teaching and Research Hapvida, Fortaleza, CE, Brazil.\', \'Hospital Nossa Senhora das Graças, Curitiba, Brazil.\', \'Department of Statistics, Institute of Mathematics and Statistics, University of Sao Paulo, São Paulo, Brazil.\', \'Northshore University Health System, Chicago, IL.\', \'Zucker School of Medicine at Hofstra/Northwell and the Feinstein Institutes for Medical Research, Manhasset, NY.\', \'Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0002-8703(21)00222-210.1016/j.ahj.2021.08.016
?:hasPublicationType
?:journal
  • American heart journal
is ?:pmid of
?:pmid
?:pmid
  • 34480880
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.267
?:rankingScore_hIndex
  • 169
?:title
  • Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34480880>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34480880>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all